Page 797 - Veterinary Immunology, 10th Edition
P. 797

VetBooks.ir  Adjuvants





               To maximize the effectiveness of vaccines, especially those
               containing killed organisms or highly purified antigens, it has been

               common practice to add substances called adjuvants to the vaccine
               (adjuvare is the Latin verb for “to help”). Adjuvants can increase the
               speed or the magnitude of the body's response to vaccines, they
               may permit reductions in the amount of antigen injected or the
               numbers of doses administered, they can induce appropriate bias in

               the response (Th1 or Th2), they may trigger cell-mediated
               immunity, and they are essential if long-term memory is to be
               established to soluble antigens. Adjuvant use is critical for the

               effectiveness of subunit or recombinant vaccines. The “science” of
               adjuvants has historically been empirical. In other words, materials
               were added to vaccines to see if they improved either the strength
               or duration of the immune response. As a result, adjuvants
               appeared to be randomly selected substances and their mechanisms

               of action were speculative. Recently, however, it has become clear
               that the commonly employed adjuvants are toll-like receptor
               ligands. Their main mode of action is to promote antigen uptake,

               processing, and presentation by dendritic cells. In general,
               adjuvants trigger innate immune responses that in turn act on
               dendritic cells to enhance antigen presentation to T or B cells (Table
               24.3). As our knowledge of the ways in which dendritic cells and T
               or B cells interact has grown, it has become possible to develop

               vaccines designed rationally to maximize antigen presentation.
               Thus the growing use of particles coated with antigen, cytokines,
               and co-stimulatory molecules as adjuvants has led to encouraging

               improvements in vaccine efficacy.


               TABLE 24.3

               Some Common Adjuvants



                Type            Adjuvant               Mode of Action
                Depot adjuvants  Aluminum phosphate    Slow-release antigen depot?
                                Aluminum hydroxide     Slow-release antigen depot?
                                Alum                   Activate DAMPs
                                Freund's incomplete adjuvant Slow antigen release depot
                Microbial adjuvants Anaerobic corynebacteria  Macrophage stimulator




                                                         797
   792   793   794   795   796   797   798   799   800   801   802